United States: Securities Litigation Defense Implications From The Supreme Court's Amgen Opinion - Jones Day
On February 27, 2013, the Supreme Court ruled in Amgen, Inc. v. Connecticut Retirement Plans and Trust Funds, No. 11-1085, that plaintiffs in a federal securities fraud action need not prove the materiality of an alleged misrepresentation to certify a class under the fraud-on-the-market theory.
action
amgen
connecticut
court
defense
implications
jones
litigation
materiality
misrepresentation
opinion
retirement
securities
states
supreme
united
Found 1 month ago on channel
Mondaq
United States: The ERISA Litigation Newsletter - Proskauer Rose LLP
A discussion on a number of recent rulings on retiree medical allowances, indemnification provisions, investment claims, consideration of evidence outside of the administrative record, statute of limitations and availability of monetary damages.
allowance
availability
consideration
discussion
erisa
evidence
indemnification
investment
limitations
litigation
llp
proskauer
provisions
states
united
Found 1 month ago on channel
Mondaq
For the poorer spouse, financing for the divorce battle
NEW YORK - When big dollars are at stake in a divorce settlement -- a situation faced by billionaire oilman Harold Hamm after his headline-grabbing breakup -- the litigation tends to drag on for months, if not years.But a protracted court battle is expensive and may seem unaffordable for the "less moneyed" spouse divorcing an estranged partner with deep pockets.That's why a mini-industry has em...
hamm
harold
litigation
settlement
situation
york
Found 1 month ago on channel
MSNBC
United States: The Fact Pattern Behind The Boeing Class Action Grounding - Foley & Lardner
The Seventh Circuit several years ago questioned its ability to rely on confidential witness allegations in securities class actions governed by the Private Securities Litigation Reform Act.
ability
act
action
allegations
boeing
circuit
foley
lardner
litigation
securities
seventh
states
united
witness
Found 1 month ago on channel
Mondaq
J&J's Profit Slips on Deal Costs
Johnson & Johnson's first-quarter profit fell 11% on litigation expenses, impacts related to its Synthes acquisition and other items, though the deal also helped boost health-care giant's sales.
acquisition
johnson
litigation
synthes